SCHEMBL742124

SCHEMBL742124

CC(C)(NC(=O)c1cc2c(NC(=O)c3cccc(F)c3)n[nH]c2s1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 3/20 0.48
ABL1 P00519 2/20 0.46
BCR P11274 2/20 0.46
CCNA2 P20248 1/20 0.43
CDK2 P24941 1/20 0.43
CCNA1 P78396 1/20 0.43
TP53 P04637 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CDC7 O00311 2/20 0.41
PLK4 O00444 1/20 0.41
CHEK1 O14757 1/20 0.41
DCLK1 O15075 1/20 0.41
MAPK13 O15264 1/20 0.41
PDPK1 O15530 1/20 0.41
DAPK3 O43293 1/20 0.41
DYRK3 O43781 1/20 0.41
JAK2 O60674 1/20 0.41
RPS6KA5 O75582 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL740292 0.91 AURKA (0.55) AURKAABL1BCRCCNA2CDK2
SCHEMBL738866 0.91 AURKA (0.53) AURKAABL1BCRCCNA2CDK2
SCHEMBL740599 0.87 AURKA (0.49) AURKAABL1BCRCCNA2CDK2
SCHEMBL740809 0.86 AURKA (0.52) AURKAABL1BCRCCNA2CDK2
SCHEMBL1779700 0.85 AURKA (0.50) AURKAABL1BCRALDH1A1POLB
SCHEMBL740955 0.85 CDK7 (0.48) AURKAABL1BCRCCNA2CDK2
SCHEMBL1778008 0.85 AURKA (0.49) AURKAABL1BCRTSHR
SCHEMBL741093 0.85 AURKA (0.46) AURKAABL1BCRCDK2TP53
SCHEMBL741311 0.85 AURKA (0.53) AURKAABL1BCRCDK2SMN1; SMN2
SCHEMBL743719 0.84 ABL1 (0.55) AURKAABL1BCRFGFR1FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed